NCT06229405View on ClinicalTrials.gov

Development of Clinical Evidence for Optimal Management of Adrenal Diseases Based on Real-World Data

RecruitingOBSERVATIONAL
Enrollment

8,200

Participants

Timeline

Start Date

May 10, 2022

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
Adrenal TumorPrimary AldosteronismCushing SyndromePheochromocytomaAdrenal Cortical Carcinoma
Trial Locations (1)

03080

RECRUITING

Seoul National University Hospital, Seoul

Sponsors

Collaborators (1)

Asan Medical Center
All Listed Sponsors
collaborator

Asan Medical Center

OTHER

collaborator

Seoul National University Bundang Hospital

OTHER

collaborator

Samsung Medical Center

OTHER

collaborator

Inha University Hospital

OTHER

collaborator

Chonnam National University Hospital

OTHER

collaborator

Nowon Eulji Medical Center

UNKNOWN

lead

Seoul National University Hospital

OTHER

NCT06229405 - Development of Clinical Evidence for Optimal Management of Adrenal Diseases Based on Real-World Data | Biotech Hunter | Biotech Hunter